Monday 19, Jul 2010
Specific drugs identified for providing relief to patients to lung and joint ailments
A recent discovery by scientists at the University of Edinburgh will help patients afflicted with inflammatory conditions such as chronic diseases of the joints, lungs, and other organs get close to relief and reduced disease activity.
According to a new study in the Nature Medicine journal, specific drugs that have already been tested for cancer patients can reduce tissue inflammation by a significant extent.
From Sciencedaily.com:
The Edinburgh scientists have spent years devising ways of inducing apoptosis in specific inflammatory cells while, in parallel, driving macrophages to clear the resultant apoptotic cells more rapidly. Now they have shown that CDK inhibitors, like Roscovitine – which is already being tested in human cancer – are capable of inducing neutrophil apoptosis ‘in the test-tube’. Significantly, laboratory tests now suggest that they also reduce inflammation in models of rheumatoid arthritis and a devastating, currently untreatable, lung disease called fibrosing alveolitis.
Professor Chris Haslett, Head of the Queen’s Medical Research Institute at the University of Edinburgh, expects the study to lead to trials of these drugs in human inflammatory diseases. Professors Adriano Rossi and Haslett, who have led this new study with other colleagues from the QMRI, said: “This study offers new hope for patients with severe inflammatory diseases. Specific treatment for such conditions is poor, and the use of steroids is fraught with potential difficulties. We have adopted a different strategy by using non-biological treatments, but this study needs urgently to be translated into trials and we are now seeking major funding to research further how these drugs work.”
CDK inhibitors and many other specific non-biological drugs could be useful for knocking out the inflammatory cells behind damage to the tissue and scarring that often leads to organ failure and joint pain, as per the involved researchers.
Tags: apoptosis, cancer, chronic diseases, steroids, use of steroids
Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids
According to a discovery by scientists at the
R-roscovitine, a drug that is presently being tested for cancer, may prove for treating asthma as well, according to a research.
According to a recent research, progression of prostate cancer and reduction in efficacy of anti-cancer drugs can be stimulated by hormonal components in over-the-counter dietary supplements.
According to Howard Hughes Medical Institute investigators at
The appearance of a rash in patients suffering from cancer and treated with erlotinib (Tarceva) is strongly associated with longer survival, as per researchers from the drug’s developer, OSI Pharmaceuticals, Inc.
Patients receiving panitumumab for treating metastatic colorectal cancer can avoid some of the skin-associated toxicities with a preemptive and prophylactic skin regimen, as per data presented at the 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco.
Rituximab, which is currently indicated to patients suffering from cancer, can also prove effective for providing relief to patients with lupus and suffering from complications of the central nervous system, as per rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria.
Treatment of multiple myeloma, a dreadful type of cancer, with
Scientists at the